Findings

What do systematic reviews say?

6 questions · 6 findings · 4 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 0 · 0%Moderate 4 · 66.7%High 1 · 16.7%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Etanercept vs placebo · CDLQI Scores range from 0 to 30. Lower scores indicate better health‐related quality of life. Calculations are based on the change from baseline to week 12 in both groups
  Anti‐TNF agents for paediatric psoriasis 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 211 participants
  Moderate
Direct match · question page
- Doxycycline vs prednisolone · Quality of life (DLQI) adjusted for baseline DLQI, disease severity, age, Karnovsky score, baseline versus week 52. A lower score is more favourable.
  Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 234 participants
  High
Direct match · question page
- Dietary intervention vs usual care · Quality of life Change in DLQI (scale from 0 to 30; lower DLQI scores represent improvement in quality of life)
  Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 36 participants
  Moderate
Direct match · question page
- Dietary intervention and exercise programme vs information only · Reduction in comorbidities Change in BMI (lower BMI is beneficial)
  Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 303 participants
  Moderate
Direct match · question page
- Dietary intervention vs usual care · Reduction in comorbidities Change in BMI (lower BMI is beneficial)
  Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 78 participants
  Moderate

Doxycycline vs prednisolone

Quality of life (DLQI) adjusted for baseline DLQI, disease severity, age, Karnovsky score, baseline versus week 52. A lower score is more favourable. · bullous pemphigoid

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 234 participants
High

Intervention not reported

Stratum corneum hydration (SCH) (at baseline and day 56 ± 4) Hahnel 2017: measured at 56 ± 4 days in mid‐volar arm and lower leg in arbitrary units from 0 (no water) to 120 (on water) using the Corneometer CM 825 Gillis 2016: measured at 12 weeks ... · people 60 years of age and older

1 finding from 1 review

Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care… 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 266 participants
Very low

Adverse event outcomes for dietary combined with physical activity interventions vs information only

Change in BMI · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 303 participants
Moderate

Dietary interventions vs usual care

Change in DLQI score (LOCF) · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Moderate

Dietary interventions vs usual care

Change in BMI · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 78 participants
Moderate

Etanercept vs placebo

CDLQI Scores range from 0 to 30. Lower scores indicate better health‐related quality of life. Calculations are based on the change from baseline to week 12 in both groups · people with paediatric psoriasis

1 finding from 1 review

Anti‐TNF agents for paediatric psoriasis 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 211 participants
Moderate